Cargando…

Pregabalin–Tolperisone Combination to Treat Neuropathic Pain: Improved Analgesia and Reduced Side Effects in Rats

The current treatment of neuropathic pain (NP) is unsatisfactory; therefore, effective novel agents or combination-based analgesic therapies are needed. Herein, oral tolperisone, pregabalin, and duloxetine were tested for their antinociceptive effect against rat partial sciatic nerve ligation (pSNL)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Essmat, Nariman, Galambos, Anna Rita, Lakatos, Péter P., Karádi, Dávid Árpád, Mohammadzadeh, Amir, Abbood, Sarah Kadhim, Geda, Orsolya, Laufer, Rudolf, Király, Kornél, Riba, Pál, Zádori, Zoltán S., Szökő, Éva, Tábi, Tamás, Al-Khrasani, Mahmoud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459435/ https://www.ncbi.nlm.nih.gov/pubmed/37631030 http://dx.doi.org/10.3390/ph16081115

Ejemplares similares

The Acute Antiallodynic Effect of Tolperisone in Rat Neuropathic Pain and Evaluation of Its Mechanism of Action
por: Lakatos, Péter P., et al.
Publicado: (2022)

Telmisartan Is a Promising Agent for Managing Neuropathic Pain and Delaying Opioid Analgesic Tolerance in Rats
por: Karádi, David Á., et al.
Publicado: (2023)

Pharmacological Evidence on Augmented Antiallodynia Following Systemic Co-Treatment with GlyT-1 and GlyT-2 Inhibitors in Rat Neuropathic Pain Model
por: Mohammadzadeh, Amir, et al.
Publicado: (2021)

Shedding Light on the Pharmacological Interactions between μ-Opioid Analgesics and Angiotensin Receptor Modulators: A New Option for Treating Chronic Pain
por: Király, Kornél, et al.
Publicado: (2021)

Recent Molecular Insights into Agonist-specific Binding to the Mu-Opioid Receptor
por: Zádor, Ferenc, et al.
Publicado: (2022)

Differential Ganglioside and Cholesterol Depletion by Various Cyclodextrin Derivatives and Their Effect on Synaptosomal Glutamate Release
por: Geda, Orsolya, et al.
Publicado: (2022)

Comparisons of In Vivo and In Vitro Opioid Effects of Newly Synthesized 14-Methoxycodeine-6-O-sulfate and Codeine-6-O-sulfate
por: Zádor, Ferenc, et al.
Publicado: (2020)

On the Role of Peripheral Sensory and Gut Mu Opioid Receptors: Peripheral Analgesia and Tolerance
por: Fürst, Susanna, et al.
Publicado: (2020)

Spinal interaction between μ and δ opioid receptors in naive and morphine-tolerant rats
por: Riba, Pál, et al.
Publicado: (2009)

Efficacy-Based Perspective to Overcome Reduced Opioid Analgesia of Advanced Painful Diabetic Neuropathy in Rats
por: Balogh, Mihály, et al.
Publicado: (2019)

Pregabalin in Chemotherapy Induced Neuropathic Pain
por: Atreya, Shrikant
Publicado: (2016)

Morphine and pregabalin in the treatment of neuropathic pain
por: Wang, Yue, et al.
Publicado: (2017)

The Pharmacological Effects of Phenylephrine are Indirect, Mediated by Noradrenaline Release from the Cytoplasm
por: Al-Khrasani, Mahmoud, et al.
Publicado: (2022)

Pregabalin in Neuropathic Pain: Evidences and Possible Mechanisms
por: Verma, Vivek, et al.
Publicado: (2014)

Synergistic Antinociceptive Effects of Indomethacin–Pregabalin and Meloxicam–Pregabalin in Paclitaxel-Induced Neuropathic Pain
por: Ma, Yurong, et al.
Publicado: (2022)

New Insights into the Opioid Analgesic Profile of cis-(−)-N-Normetazocine-derived Ligands
por: Costanzo, Giuliana, et al.
Publicado: (2023)

Clinical use of pregabalin in the management of central neuropathic pain
por: Finnerup, Nanna B, et al.
Publicado: (2007)

Pregabalin in post traumatic neuropathic pain: Case studies
por: Singh, Rakesh Kumar, et al.
Publicado: (2012)

Duloxetine and pregabalin in neuropathic pain of lung cancer patients
por: Gül, Şule Karabulut, et al.
Publicado: (2020)

Pregabalin in the Treatment of Peripheral and Central Chronic Neuropathic Pain
por: Prnjavorac, Besim, et al.
Publicado: (2023)

Basic Aspects of the Pharmacodynamics of Tolperisone, A Widely Applicable Centrally Acting Muscle Relaxant
por: Tekes, Kornelia
Publicado: (2014)

The Nonsteroidal Anti-Inflammatory Drug Ketorolac Alters the Small Intestinal Microbiota and Bile Acids Without Inducing Intestinal Damage or Delaying Peristalsis in the Rat
por: Hutka, Barbara, et al.
Publicado: (2021)

Comparison of central versus peripheral delivery of pregabalin in neuropathic pain states
por: Martinez, Jose A, et al.
Publicado: (2012)

A Comprehensive Drug Safety Evaluation of Pregabalin in Peripheral Neuropathic Pain
por: Freynhagen, Rainer, et al.
Publicado: (2015)

The antiallodynic action of pregabalin in neuropathic pain is independent from the opioid system
por: Kremer, Mélanie, et al.
Publicado: (2016)

Pregabalin treatment for neuropathic pain may damage intervertebral disc tissue
por: Karaarslan, Numan, et al.
Publicado: (2018)

Effect of duloxetine on neuropathic pain in patients intolerant to continuous administration of pregabalin
por: Shimada, Yohei, et al.
Publicado: (2017)

Synthesis and Pharmacological Activities of 6-Glycine Substituted 14-Phenylpropoxymorphinans, a Novel Class of Opioids with High Opioid Receptor Affinities and Antinociceptive Potencies
por: Spetea, Mariana, et al.
Publicado: (2011)

The comparative study of clinical efficacy and safety of baclofen vs tolperisone in spasticity caused by spinal cord injury
por: Luo, Dejun, et al.
Publicado: (2017)

An assessment of the centrally acting muscle relaxant tolperisone on driving ability and cognitive effects compared to placebo and cyclobenzaprine
por: Caron, Judy, et al.
Publicado: (2020)

Screen-printed sensors for efficient potentiometric analysis of tolperisone hydrochloride in presence of its co-formulated drugs
por: Rizk, Mohamed, et al.
Publicado: (2022)

Retraction: Comparison of central versus peripheral delivery of pregabalin in neuropathic pain states
por: Martinez, Jose A, et al.
Publicado: (2014)

Sustained-release pregabalin with methylcobalamin in neuropathic pain: an Indian real-life experience
por: Dongre, Yasmin U, et al.
Publicado: (2013)

Capsaicin 8% patch versus oral pregabalin in patients with peripheral neuropathic pain
por: Haanpää, M., et al.
Publicado: (2015)

Factors predicting adverse events associated with pregabalin administered for neuropathic pain relief
por: Kanbayashi, Yuko, et al.
Publicado: (2014)

Clinical Comparative Study: Efficacy and Tolerability of Tolperisone and Thiocolchicoside in Acute Low Back Pain and Spinal Muscle Spasticity
por: Rao, Rajeev, et al.
Publicado: (2012)

Development and Validation of a Precise, Single HPLC Method for the Determination of Tolperisone Impurities in API and Pharmaceutical Dosage Forms
por: Raju, Thummala Veera Raghava, et al.
Publicado: (2013)

Sustainable Removal of Tolperisone from Waters by Application of Photocatalysis, Nanotechnology, and Chemometrics: Quantification, Environmental Toxicity, and Degradation Optimization
por: Bognár, Szabolcs, et al.
Publicado: (2022)

Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial
por: Tesfaye, Solomon, et al.
Publicado: (2022)

Antiallodynic Effect of Pregabalin in Rat Models of Sympathetically Maintained and Sympathetic Independent Neuropathic Pain
por: Han, Dong Woo, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_1rfsf5srfngr4tki46tjf5s4b6